BACKGROUND: Monitoring urinary albumin is a useful method in clinical practice for the management of diabetic nephropathy, chronic kidney disease, and hypertension. Currently there are neither standardized methods nor reference material for the determination of urinary albumin; for this reason it is useful to compare different assays used in clinical laboratory. OBJECTIVES: The aim of this study is to verify analytical performance of an immunoturbidimetric assay on Roche Cobas 8000 platform and to compare urinary albumin results with those obtained by immunonephelometry on Siemens Dade Behring BN II Nephelometer. RESULTS: The method comparison showed a good linear relationship, confirmed by Passing-Bablok and Bland-Altman plots. The turbidimetric assay meets the requirements of accuracy and precision for the practice of medical diagnostics and clinical use. CONCLUSIONS: The present study can contribute to the methods standardization and harmonization of urinary albumin assay.
BACKGROUND: Monitoring urinary albumin is a useful method in clinical practice for the management of diabetic nephropathy, chronic kidney disease, and hypertension. Currently there are neither standardized methods nor reference material for the determination of urinary albumin; for this reason it is useful to compare different assays used in clinical laboratory. OBJECTIVES: The aim of this study is to verify analytical performance of an immunoturbidimetric assay on Roche Cobas 8000 platform and to compare urinary albumin results with those obtained by immunonephelometry on Siemens Dade Behring BN II Nephelometer. RESULTS: The method comparison showed a good linear relationship, confirmed by Passing-Bablok and Bland-Altman plots. The turbidimetric assay meets the requirements of accuracy and precision for the practice of medical diagnostics and clinical use. CONCLUSIONS: The present study can contribute to the methods standardization and harmonization of urinary albumin assay.
Authors: C Ricós; V Alvarez; F Cava; J V García-Lario; A Hernández; C V Jiménez; J Minchinela; C Perich; M Simón Journal: Scand J Clin Lab Invest Date: 1999-11 Impact factor: 1.713
Authors: Jacoline W Brinkman; Stephan J L Bakker; Ron T Gansevoort; Hans L Hillege; Ido P Kema; Reinold O B Gans; Paul E de Jong; Dick de Zeeuw Journal: Kidney Int Suppl Date: 2004-11 Impact factor: 10.545
Authors: Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan Journal: Ann Intern Med Date: 2003-07-15 Impact factor: 25.391
Authors: Aisha Shaikh; Jesse C Seegmiller; Timothy M Borland; Bradley E Burns; Paula M Ladwig; Ravinder J Singh; Rajiv Kumar; Timothy S Larson; John C Lieske Journal: Clin Chem Date: 2008-07-10 Impact factor: 8.327
Authors: W Greg Miller; David E Bruns; Glen L Hortin; Sverre Sandberg; Kristin M Aakre; Matthew J McQueen; Yoshihisa Itoh; John C Lieske; David W Seccombe; Graham Jones; David M Bunk; Gary C Curhan; Andrew S Narva Journal: Clin Chem Date: 2008-11-21 Impact factor: 8.327
Authors: Diana Nabrdalik-Leśniak; Katarzyna Nabrdalik; Katarzyna Sedlaczek; Patryk Główczyński; Hanna Kwiendacz; Tomasz Sawczyn; Weronika Hajzler; Karolina Drożdż; Mirela Hendel; Krzysztof Irlik; Paweł Stelmach; Piotr Adamczyk; Andrzej Paradysz; Sławomir Kasperczyk; Tomasz Stompór; Janusz Gumprecht Journal: Oxid Med Cell Longev Date: 2021-07-14 Impact factor: 6.543